Certara introduces the D360 Express data platform for pharmaceutical R&D

Packaged informatics solution reduces research cycle time, delivering faster insights for busy discovery scientists

Certara, the leading provider of decision support technology and consulting services for optimising drug development and improving health outcomes, has announced the availability of D360 Express.

This R&D informatics platform provides scientific data integration, analysis and visualisation in an easy-to-deploy, self-service solution specifically packaged for discovery scientists at small biopharmaceutical companies.

‘The feedback that we have received from the 6500 scientists using D360 has been overwhelmingly positive with regard to the platform’s ability to reduce research cycle times, enabling them to make quicker, more effective decisions,’ said Certara Chief Executive Officer Edmundo Muniz, MD, PhD.

‘Those scientists estimate that by using D360 they have been able to increase by more than 50% the time they spend performing pivotal scientific modeling and analysis instead of provisioning data.’

With D360 Express, Certara has taken the D360 features and benefits that have proven so valuable to larger pharmaceutical R&D groups and created a solution tailored to the needs of discovery scientists in smaller organisations.

D360 is a scientifically intelligent data access solution for small molecule discovery scientists. It combines data from multiple cheminformatics and bioinformatics databases, allowing users to query those sources in a common GUI. D360 also enables those scientists to visualise their query results and make informed go/no go and next step decisions.

Companies